- Report
- January 2022
- 60 Pages
Global
From €3787EUR$3,950USD£3,164GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1917EUR$2,000USD£1,602GBP
The Personality Disorder Drug market is a subset of the Mental Disorders Drugs market, focusing on drugs used to treat personality disorders. These drugs are typically used to treat symptoms such as impulsivity, aggression, and difficulty with interpersonal relationships. Commonly prescribed drugs include antipsychotics, antidepressants, and mood stabilizers. These drugs are often used in combination with psychotherapy to help patients manage their symptoms.
The Personality Disorder Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Eli Lilly, Johnson & Johnson, GlaxoSmithKline, and AstraZeneca. Other companies such as Novartis, Merck, and AbbVie also offer drugs for the treatment of personality disorders. Show Less Read more